{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:50:00Z","timestamp":1759366200733,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004231","name":"Grupa Adamed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004231","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejmech.2020.112149","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T19:38:24Z","timestamp":1582054704000},"page":"112149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD)"],"prefix":"10.1016","volume":"191","author":[{"given":"Adam","family":"Bucki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Marcinkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"\u015aniecikowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Zag\u00f3rska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Jamrozik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Paw\u0142owski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"G\u0142uch-Lutwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Jakubczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Pytka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Jastrz\u0119bska-Wi\u0119sek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Partyka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Weso\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Mierzejewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Ko\u0142aczkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"WHO","key":"10.1016\/j.ejmech.2020.112149_bib1"},{"key":"10.1016\/j.ejmech.2020.112149_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00019442-200002000-00004","article-title":"Psychosis of Alzheimer\u2019s disease and related dementias: diagnostic criteria for a distinct syndrome","volume":"8","author":"Jeste","year":"2000","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.ejmech.2020.112149_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0197-4580(94)90024-8","article-title":"Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions","volume":"15","author":"Arnold","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2020.112149_bib4","first-page":"30","article-title":"About a peculiar disease of the cerebral cortex","volume":"2","author":"Strassnig","year":"2005","journal-title":"Psychiatr. Edgmont"},{"key":"10.1016\/j.ejmech.2020.112149_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-3223(02)01348-3","article-title":"Depression in Alzheimer\u2019s disease: overview and treatment","volume":"52","author":"Lyketsos","year":"2002","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejmech.2020.112149_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/CIA.S1698","article-title":"Management of the behavioral and psychological symptoms of dementia","volume":"2","author":"Hersch","year":"2007","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejmech.2020.112149_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.npp.1301492","article-title":"ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia","volume":"33","author":"Jeste","year":"2008","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2020.112149_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/YCO.0b013e32833111f9","article-title":"Management of agitation and aggression associated with Alzheimer\u2019s disease: controversies and possible solutions","volume":"22","author":"Ballard","year":"2009","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.ejmech.2020.112149_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.JGP.0000196628.12010.35","article-title":"Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial","volume":"14","author":"Tariot","year":"2006","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.ejmech.2020.112149_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11940-019-0572-3","article-title":"Treatment options for agitation in dementia","volume":"21","author":"Ringman","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.ejmech.2020.112149_bib11","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.2174\/138920112800784880","article-title":"Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia","volume":"13","author":"Meltzer","year":"2012","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.ejmech.2020.112149_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1474-4422(18)30039-5","article-title":"ADP Investigators, Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer\u2019s disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study","volume":"17","author":"Ballard","year":"2018","journal-title":"Lancet Neurol."},{"year":"2020","series-title":"Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates, CNS Drugs","author":"Marcinkowska","key":"10.1016\/j.ejmech.2020.112149_bib14"},{"key":"10.1016\/j.ejmech.2020.112149_bib15","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S1474-4422(14)70198-X","article-title":"Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer\u2019s disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"13","author":"Wilkinson","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2020.112149_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuropharm.2017.07.010","article-title":"Antagonism of the 5-HT6 receptor - preclinical rationale for the treatment of Alzheimer\u2019s disease","volume":"125","author":"de Jong","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2020.112149_bib17","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.7b01898","article-title":"Structure\u2013activity relationships and therapeutic potentials of 5-HT7 receptor ligands: an update","author":"Modica","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01045","article-title":"Antipsychotic treatment of behavioral and psychological symptoms of dementia (BPSD): management of extrapyramidal side effects","volume":"10","author":"Ohno","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112149_bib19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1021\/ci300413h","article-title":"Ligand-optimized homology models of D1 and D2 dopamine receptors: application for virtual screening","volume":"53","author":"Ko\u0142aczkowski","year":"2013","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2020.112149_bib20","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1021\/acs.jmedchem.7b00839","article-title":"Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based multifunctional ligands with antipsychotic-like, mood-modulating, and procognitive activity","volume":"60","author":"Bucki","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2016.08.016","article-title":"Novel multi-target-directed ligands for Alzheimer\u2019s disease: combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation","volume":"124","author":"Wi\u0119ckowska","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1232808","article-title":"Structural features for functional selectivity at serotonin receptors","volume":"340","author":"Wacker","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112149_bib23","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1093\/nar\/gkg557","article-title":"GeneSilico protein structure prediction meta-server","volume":"31","author":"Kurowski","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2020.112149_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-61779-588-6_5","article-title":"Automated protein structure modeling with SWISS-model workspace and the protein model portal","volume":"857","author":"Bordoli","year":"2012","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"10.1016\/j.ejmech.2020.112149_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2020.112149_bib26","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib27","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","article-title":"Central nervous system multiparameter optimization desirability: application in drug discovery","volume":"7","author":"Wager","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112149_bib29","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112149_bib30","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1002\/j.1460-2075.1987.tb02733.x","article-title":"Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors","volume":"6","author":"Peralta","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2020.112149_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00179179","article-title":"The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions","volume":"90","author":"Ogren","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2020.112149_bib32","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejmech.2020.112149_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0028-3908(71)90074-8","article-title":"Evaluation of a rapid technique for detecting minor tranquilizers","volume":"10","author":"Aron","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2020.112149_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11011-016-9932-9","article-title":"HBK-14 and HBK-15 with antidepressant-like and\/or memory-enhancing properties increase serotonin levels in the hippocampus after chronic treatment in mice","volume":"32","author":"Pytka","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejmech.2020.112149_bib35","first-page":"54","article-title":"HBK-15 protects mice from stress-induced behavioral disturbances and changes in corticosterone, BDNF, and NGF levels, Behav","volume":"333","author":"Pytka","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2020.112149_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00210-014-0966-4","article-title":"Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia","volume":"387","author":"Ko\u0142aczkowski","year":"2014","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112149_bib37","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1021\/jm401895u","article-title":"Novel arylsulfonamide derivatives with 5-HT6\/5-HT7 receptor antagonism targeting behavioral and psychological symptoms of dementia","volume":"57","author":"Ko\u0142aczkowski","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejmech.2014.12.045","article-title":"Novel 5-HT6 receptor antagonists\/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia","volume":"92","author":"Ko\u0142aczkowski","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/jm970519e","article-title":"N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist","volume":"41","author":"Forbes","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib40","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1021\/jm970424c","article-title":"6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5- pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist","volume":"40","author":"Bromidge","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ddr.430030305","article-title":"The preclinical antipsychotic evaluation of HRP 913, a novel benzisoxazole derivative","volume":"3","author":"Fielding","year":"1983","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2020.112149_bib42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0014-2999(96)00840-0","article-title":"Iloperidone binding to human and rat dopamine and 5-HT receptors","volume":"317","author":"Kongsamut","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112149_bib43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1176\/ajp.151.6.825","article-title":"Risperidone in the treatment of schizophrenia","volume":"151","author":"Marder","year":"1994","journal-title":"Am. J. Psychiatr."},{"author":"al et","key":"10.1016\/j.ejmech.2020.112149_bib44"},{"key":"10.1016\/j.ejmech.2020.112149_bib45","unstructured":"M. Kolaczkowski, M. Marcinkowska, A. Bucki, M. Pawlowski, A. Krukowski, R. Rusiecki, A.M. Siwek, M.A. Wolak, Sulphonamide Derivatives of Alicyclic Amines for the Treatment of Central Nervous System Diseases, WO2013001505 (A2), 03.01.2013, 2013."},{"key":"10.1016\/j.ejmech.2020.112149_bib46","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1021\/jm060300c","article-title":"Receptor-based pharmacophores for serotonin 5-HT7R antagonists-implications to selectivity","volume":"49","author":"Ko\u0142aczkowski","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112149_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/cbdd.13442","article-title":"Characteristics of metabolic stability and the cell permeability of 2-pyrimidinyl-piperazinyl-alkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione with antidepressant- and anxiolytic-like activities","volume":"93","author":"Zag\u00f3rska","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112149_bib48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02246184","article-title":"Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability","volume":"120","author":"Hoffman","year":"1995","journal-title":"Psychopharmacology"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420301161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420301161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:06:33Z","timestamp":1759327593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420301161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":47,"alternative-id":["S0223523420301161"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112149","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112149"}}